Elisabetta Schiaroli Selected Research

Elisabetta Schiaroli Research Topics

Disease

11	Infections 02/2024 - 03/2012
10	COVID-19 02/2024 - 01/2021
5	Inflammation (Inflammations) 01/2022 - 01/2012
3	HIV Infections (HIV Infection) 01/2022 - 05/2013
3	Atherosclerosis 04/2019 - 01/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2013
2	Pneumonia (Pneumonitis) 11/2021 - 06/2016
1	Osteomyelitis 02/2024
1	Surgical Wound Infection 02/2024
1	Abscess 02/2024
1	Cellulitis 02/2024
1	Infectious Arthritis (Septic Arthritis) 02/2024
1	Communicable Diseases (Infectious Diseases) 12/2023
1	Feline Infectious Peritonitis 03/2023
1	Severe Acute Respiratory Syndrome 01/2023
1	Staphylococcal Infections 01/2020
1	Tobacco Use Disorder (Nicotine Dependence) 01/2020
1	Carotid Artery Diseases 04/2019
1	Hypercholesterolemia 01/2019
1	Myocardial Infarction 01/2018
1	Hypertension (High Blood Pressure) 07/2017
1	Central Nervous System Infections (Central Nervous System Infection) 06/2016
1	Nocardia Infections 06/2016
1	Urinary Tract Infections (Urinary Tract Infection) 01/2015
1	Aspiration Pneumonia 01/2015
1	Meningitis 01/2015
1	Coronary Disease (Coronary Heart Disease) 05/2013
1	Dyslipidemias (Dyslipidemia) 05/2013
1	Disease Progression 03/2012
1	Hematologic Neoplasms (Hematological Malignancy) 03/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2012
1	Virus Diseases (Viral Diseases) 01/2012

Drug/Important Bio-Agent (IBA)

2	cilgavimabIBA 02/2024 - 01/2023
2	tixagevimabIBA 02/2024 - 01/2023
2	nirmatrelvirIBA 03/2023 - 01/2023
2	Antiviral Agents (Antivirals)IBA 03/2023 - 06/2021
2	remdesivirIBA 01/2023 - 12/2022
2	VaccinesIBA 01/2022 - 10/2021
2	bamlanivimabIBA 01/2022 - 01/2021
2	Proprotein Convertase 9IBA 06/2021 - 01/2019
2	Maraviroc FDA Link 04/2019 - 05/2013
2	LipidsIBA 01/2019 - 10/2012
2	Ritonavir (Norvir)FDA Link 05/2013 - 01/2012
2	Protease Inhibitors (Protease Inhibitor)IBA 05/2013 - 01/2012
1	dalbavancinIBA 02/2024
1	imidazole mustard (BIC)IBA 12/2023
1	Peptide Hydrolases (Proteases)FDA Link 03/2023
1	GC376IBA 03/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	molnupiravirIBA 12/2022
1	Nelfinavir (Viracept)FDA Link 12/2022
1	casirivimab and imdevimab drug combinationIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	BNT162 VaccineIBA 10/2021
1	AntigensIBA 09/2021
1	Viral RNAIBA 09/2021
1	Toll-Like Receptor 7IBA 01/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	HDL CholesterolIBA 01/2020
1	CholesterolIBA 01/2019
1	abacavir (Ziagen)FDA Link 01/2018
1	Reverse Transcriptase InhibitorsIBA 01/2018
1	NucleosidesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 12/2017
1	DNA (Deoxyribonucleic Acid)IBA 06/2016
1	Formaldehyde (Formol)FDA Link 06/2016
1	Amoxicillin (Wymox)FDA LinkGeneric 06/2016
1	ParaffinIBA 06/2016
1	Levofloxacin (Levaquin)FDA Link 06/2016
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 06/2016
1	methanesulfonic acid (methanesulfonate)IBA 01/2015
1	TeicoplaninIBA 01/2015
1	Meropenem (Merrem)FDA LinkGeneric 01/2015
1	Colistin (Coly-Mycin)FDA Link 01/2015
1	Apolipoproteins E (ApoE)IBA 05/2013
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2012
1	Viral ProteinsIBA 01/2012
1	Leflunomide (Arava)FDA LinkGeneric 01/2012

Therapy/Procedure

5	Therapeutics 01/2020 - 03/2012
3	Art Therapy 12/2023 - 01/2019
1	Prostheses and Implants (Prosthesis) 02/2024
1	Aftercare (After-Treatment) 11/2023
1	Noninvasive Ventilation 11/2021
1	Joint Prosthesis 01/2020
1	Device Removal (Removal, Device) 01/2020
1	Drug Therapy (Chemotherapy) 03/2012
1	Highly Active Antiretroviral Therapy (HAART) 01/2012